OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice
Yifan Zhang, Min Du, Jiarou Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Yifan Zhang, Min Du, Jiarou Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Showing 17 citing articles:
Review on the protective mechanism of astragaloside IV against cardiovascular diseases
Chunkun Yang, Qingquan Pan, Kui Ji, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Chunkun Yang, Qingquan Pan, Kui Ji, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Modulation of atherosclerosis‐related signaling pathways by Chinese herbal extracts: Recent evidence and perspectives
Changxing Liu, Xinyi Guo, Xulong Zhang
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2892-2930
Closed Access | Times Cited: 7
Changxing Liu, Xinyi Guo, Xulong Zhang
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2892-2930
Closed Access | Times Cited: 7
Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways
Tianwei Meng, Xinghua Li, Chengjia Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Tianwei Meng, Xinghua Li, Chengjia Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Integrated metabolomics and network pharmacology analysis to reveal the mechanisms of naringin against atherosclerosis
Gaoning Zhang, Xiaoyi Yin, Xiao Tang, et al.
Journal of Pharmacy and Pharmacology (2025)
Closed Access
Gaoning Zhang, Xiaoyi Yin, Xiao Tang, et al.
Journal of Pharmacy and Pharmacology (2025)
Closed Access
Oleanolic Acid@SPIONs Alleviates Lipid-Oxidative Stress Injury of Zebrafish Blood Vessels via Regulating the Expression of JNK and MAPK Signaling Pathways in Vascular Endothelial Cells
Hongguo Gao, Te Liu, Junfeng Liu, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 2921-2940
Open Access
Hongguo Gao, Te Liu, Junfeng Liu, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 2921-2940
Open Access
Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms
Junting Dai, Lulu Qiu, Yimin Lu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Junting Dai, Lulu Qiu, Yimin Lu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Advances in the Bioactivities of Phytochemical Saponins in the Prevention and Treatment of Atherosclerosis
Huiyu Luo, Junbin Chen, Chuhong Su, et al.
Nutrients (2022) Vol. 14, Iss. 23, pp. 4998-4998
Open Access | Times Cited: 14
Huiyu Luo, Junbin Chen, Chuhong Su, et al.
Nutrients (2022) Vol. 14, Iss. 23, pp. 4998-4998
Open Access | Times Cited: 14
Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease
Linzhang Zhang, Yonghong Hu, Shenglan Qi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Linzhang Zhang, Yonghong Hu, Shenglan Qi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII
Wanting Qin, Shaoling Li, Ziji Cheng, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24779-e24779
Open Access | Times Cited: 2
Wanting Qin, Shaoling Li, Ziji Cheng, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24779-e24779
Open Access | Times Cited: 2
Effect of High Magnesium and Astragaloside IV on Vascular Endothelial Cells
Hongfei Qi, Teng Ge, Kun Wang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 987-996
Closed Access | Times Cited: 2
Hongfei Qi, Teng Ge, Kun Wang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 987-996
Closed Access | Times Cited: 2
Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation
Sijin Li, Ping Liu, Xiaoteng Feng, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Sijin Li, Ping Liu, Xiaoteng Feng, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Ferroptosis: Latest evidence and perspectives on plant‐derived natural active compounds mitigating doxorubicin‐induced cardiotoxicity
Boyu Wang, Jiameng Wang, Changxing Liu, et al.
Journal of Applied Toxicology (2024)
Closed Access | Times Cited: 1
Boyu Wang, Jiameng Wang, Changxing Liu, et al.
Journal of Applied Toxicology (2024)
Closed Access | Times Cited: 1
Effectiveness and Safety of Qishen Yiqi Dripping Pill in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: 3-Year Results from a Multicentre Cohort Study
Ruina Bai, Feng Gu, Qianzi Che, et al.
Chinese Journal of Integrative Medicine (2024) Vol. 30, Iss. 10, pp. 877-885
Closed Access | Times Cited: 1
Ruina Bai, Feng Gu, Qianzi Che, et al.
Chinese Journal of Integrative Medicine (2024) Vol. 30, Iss. 10, pp. 877-885
Closed Access | Times Cited: 1
Effects and Potential Mechanism of Zhuyu Pill Against Atherosclerosis: Network Pharmacology and Experimental Validation
Yingying Pan, Xianrong Feng, Wei Song, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 597-612
Open Access | Times Cited: 3
Yingying Pan, Xianrong Feng, Wei Song, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 597-612
Open Access | Times Cited: 3
Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
Junlan Tan, Jian Yi, Xianya Cao, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1963-1978
Open Access | Times Cited: 3
Junlan Tan, Jian Yi, Xianya Cao, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1963-1978
Open Access | Times Cited: 3
Could Cyclosiversioside F Serve as a Dietary Supplement to Prevent Obesity and Relevant Disorders?
Siqi Qin, Junren Chen, Kexin Zhong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13762-13762
Open Access | Times Cited: 2
Siqi Qin, Junren Chen, Kexin Zhong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13762-13762
Open Access | Times Cited: 2
Astragaloside IV improves renal function and alleviates renal damage and inflammation in rats with chronic glomerulonephritis
DONG ZHANG, ZONGYING LI, Yuan Gao, et al.
TURKISH JOURNAL OF BIOLOGY (2023) Vol. 47, Iss. 1, pp. 61-73
Open Access | Times Cited: 1
DONG ZHANG, ZONGYING LI, Yuan Gao, et al.
TURKISH JOURNAL OF BIOLOGY (2023) Vol. 47, Iss. 1, pp. 61-73
Open Access | Times Cited: 1
